Followers | 32 |
Posts | 2669 |
Boards Moderated | 0 |
Alias Born | 02/18/2005 |
![](https://investorshub.advfn.com/uicon/53156.png?cb=1636020521)
Friday, October 14, 2022 8:03:32 AM
Recent SHPH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 09:23:05 PM
- Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease • GlobeNewswire Inc. • 09/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 08:26:42 PM
- Shuttle Pharma Provides Second Quarter 2024 Corporate Update • GlobeNewswire Inc. • 09/04/2024 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/04/2024 01:54:28 AM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 09/04/2024 01:52:57 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 09/04/2024 01:51:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 01:00:44 PM
- Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/28/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:10:24 PM
- Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1) • GlobeNewswire Inc. • 08/26/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:15:21 PM
- Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma • GlobeNewswire Inc. • 08/14/2024 08:10:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2024 10:08:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 01:45:58 PM
- Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE • GlobeNewswire Inc. • 07/19/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:59:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 01:00:15 PM
- Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer • GlobeNewswire Inc. • 06/18/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 06/10/2024 10:12:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:15:20 PM
- Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 • GlobeNewswire Inc. • 05/22/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:00:22 PM
- Shuttle Pharma Provides First Quarter 2024 Corporate Update • GlobeNewswire Inc. • 05/14/2024 01:00:00 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM